Jeffrey A. Bubis
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 6
- Lung Cancer Research Studies 3
- Pancreatic and Hepatic Oncology Research 2
-
- Lung Cancer Treatments and Mutations 2
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Joachim von Pawel (3 shared papers)Martin Reck (3 shared papers)J. Mezger (3 shared papers)Markus F. Renschler (3 shared papers)Paul Lorigan (3 shared papers)Robert M. Jotte (3 shared papers)Manuel Dómine (3 shared papers)Martin Steins (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Blood (2 papers)Cytometry Part B Clinical Cytometry (2 papers)Seminars in Oncology (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Jeffrey A. Bubis
14 papers receiving 387 citations
Peers
Comparison fields: 5 of 30
- Oncology 266
- Epidemiology 129
- Transplantation 10
- Nephrology 25
- Immunology 74
Countries citing papers authored by Jeffrey A. Bubis
This map shows the geographic impact of Jeffrey A. Bubis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Bubis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Bubis more than expected).
Fields of papers citing papers by Jeffrey A. Bubis
This network shows the impact of papers produced by Jeffrey A. Bubis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Bubis. The network helps show where Jeffrey A. Bubis may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey A. Bubis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 237 | |
| 2 | 2013 | 42 | |
| 3 | 2011 | 40 | |
| 4 | 2013 | 25 | |
| 5 | 2005 | 21 | |
| 6 | 2009 | 9 | |
| 7 | 2013 | 7 | |
| 8 | 2012 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2005 | 2 | |
| 11 | 2005 | 2 | |
| 12 | 2012 | 2 | |
| 13 | 2004 | 1 | |
| 14 | 2004 | 1 |
About Jeffrey A. Bubis
Jeffrey A. Bubis is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Hematology and Molecular Biology, having authored 14 papers that have together received 394 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (4 papers), Lung Cancer Research Studies (3 papers), Complement system in diseases (3 papers), Acute Myeloid Leukemia Research (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer therapeutics and mechanisms (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (266 citations), Epidemiology (129 citations), Transplantation (10 citations), Nephrology (25 citations) and Immunology (74 citations). Jeffrey A. Bubis has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Joachim von Pawel, Martin Reck, J. Mezger, Markus F. Renschler, Paul Lorigan, Robert M. Jotte, Manuel Dómine, Martin Steins, Mark A. Socinski and David R. Spigel. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cytometry Part B Clinical Cytometry, Seminars in Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.